Relevance of immunological variables in neuroborreliosis and multiple sclerosis

Acta Neurologica Scandinavica

Volumn 112, Issue 2, 2005, Pages 97-102

  Bednarova J ^a   Stourac P ^a   Adam, P ^b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Immunological variables; MRZ reaction; Multiple sclerosis; Neuroborreliosis

Indexed keywords

HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; OLIGOCLONAL BAND; RUBELLA ANTIBODY; SERUM ALBUMIN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA INFECTION; CELL COUNT; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOLOGY; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MEASLES RUBELLA VARICELLA ZOSTER REACTION; MULTIPLE SCLEROSIS; NEUROBORRELIOSIS;

ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHICKENPOX; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LYME NEUROBORRELIOSIS; MEASLES; MEASLES VIRUS; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RUBELLA; RUBELLA VIRUS;

EID: 22344438074     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00418.x     Document Type: Article

References (18)

1. PACHNER AR, STEERE AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis and radiculoneuritis. Neurology 1985;35:47-53.
2. FELGENHAUER K. Laboratory diagnosis of neurological diseases. In: Thomas L, ed. Clinical laboratory diagnostics. Frankfurt: TH Books, 1998;1308-26.
3. BERGLUND J, STJERNBERG L, ORNSTEIN K et al. 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002;34:421-5.
4. VRETHEM M, HELLBLOM L, WIDLUND M et al. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand 2002;106:205-8.
5. JANOVSKA D. Lyme borreliosis - epidemiology in Czech Republic. In: Bartùnèk P, ed. Lymeská borrelióza. Prague: Grada Publishing, 2001; 19-32.
6. RANSOHOFF R, BENVENISTE E, CADAVID D. Neuroimmunology. In: Continuum. Philadelphia: Lippincott Williams and Wilkins, 2001;7:7-42.
7. HASSLER D, ZOLLER L, HAUDE M, HUFNAGEL HD, SONNTAG HD. Lyme borreliosis in a European endemic region. Antibody prevalence and spectrum of clinical presentation. Dtsch Med Wschr 1992;117:67-74.
8. VOLKER B. Lyme borreliosis. In: Thomas L, ed. Clinical laboratory diagnostics. Frankfurt: TH Books, 1998;1174-8.
9. REIBER H, UNGEFEHR S, JACOBI CH. The intrathecal, poly-specific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998;4:111-7.
10. TUMANI H, NOELKER G, REIBER H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 1995;45:1663-70.
11. REIBER H, LANGE P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37:1153-60.
12. REIBER H, PETER JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001;184:101-22.
13. QUENTIN C, REIBER H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. AJO 2004;138:46-54.
14. GRAEF IT, HENZE T, REIBER H. Polyspezifische Immunreaktion in ZNS bei Autoimmunerkrankung mit ZNS Beteiligung. Z Artztl Fortbild 1994;88:587-91.
15. COLE SR, BECK RW, MOKE PS, KAUFMAN DI, TOURTELLOTE WW. The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group. Neurology 1998;51:885-7.
16. FILLIPINI G, COMI GC, COSI V et al. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol 1994;241:132-7.
17. MORRISSEY SP, MILLER DH, KENDALL BE et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993;116:135-46.
18. REIBER H. Cerebrospinal fluid analysis. In: Thompson EJ, Trojano M, Livrea P, eds. CSF analysis in multiple sclerosis. Milano: Springer-Verlag, 1996:51-72.